In the evolving world of precision medicine, the need for methods that can measure biomolecules with supreme accuracy and specificity is paramount. Recognizing this, Associate Professor Yan Xu of the Graduate School of Engineering at Osaka Metropolitan University and his international research team have made a great stride in this direction. They have developed an innovative nanofluidic device capable of capturing single proteins stochastically and detecting them digitally at their naturally high concentrations. This breakthrough could potentially lay the foundation for the future of personalized disease prevention and treatment.
FDA expands approval of Dupixent for eosinophilic esophagitis in children – Pharmaceutical Technology
Share this article Patients aged 1–11 years and weighing at least 15kg with the oesophageal allergic inflammation will now have access to the drug. Credit:
January 26, 2024